Individual generic drug information

cetrorelix

Reference monograph

Part of registered formulation

CETRORELIX

Reference record: Cetrorelix
Source: BNF 80 (2020–2021)
Printed source pages: 800
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Cetrorelix only.

Indications And Dose

Adjunct in the treatment of female infertility (initiated under specialist supervision) Endocrine system ▶BY SUBCUTANEOUS INJECTION ▶Adult (female): 250 micrograms once daily, dose to be administered in the morning, starting on day 5 or 6 of ovarian stimulation with gonadotrophins (or each evening starting on day 5 of ovarian stimulation), continue throughout administration of gonadotrophin including day of ovulation induction (or evening before ovulation induction), dose to be injected into the lower abdominal wall.

Source page 800

Safety

Extracted information for Cetrorelix only.

Side Effects

▶Common or very common Ovarian hyperstimulation syndrome ▶Uncommon Headache. hypersensitivity. nausea

Source page 800

Pregnancy

Avoid in conﬁrmed pregnancy.

Source page 800

Breast Feeding

Avoid.

Source page 800

Hepatic Impairment

Manufacturer advises use with caution—no information available.

Source page 800

Renal Impairment

Avoid in moderate or severe renal impairment.

Source page 800

Dose and formulations

Extracted information for Cetrorelix only.

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Powder and solvent for solution for injection ▶Cetrotide (Merck Serono Ltd) Cetrorelix (as Cetrorelix acetate) 250 microgram Cetrotide 250microgram powder and solvent for solution for injection vials | 1 vial P £27.13 DT = £27.13

Source page 800

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

First line only; read the complete Indications and dose section above.

250 micrograms once daily, dose to be

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 800

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

cetrorelix

Reference monograph

Part of registered formulation

CETRORELIX

Reference record: Cetrorelix
Source: BNF 80 (2020–2021)
Printed source pages: 800
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Cetrorelix only.

Indications And Dose

Source page 800

Safety

Extracted information for Cetrorelix only.

Side Effects

▶Common or very common Ovarian hyperstimulation syndrome ▶Uncommon Headache. hypersensitivity. nausea

Source page 800

Pregnancy

Avoid in conﬁrmed pregnancy.

Source page 800

Breast Feeding

Avoid.

Source page 800

Hepatic Impairment

Manufacturer advises use with caution—no information available.

Source page 800

Renal Impairment

Avoid in moderate or severe renal impairment.

Source page 800

Dose and formulations

Extracted information for Cetrorelix only.

Medicinal Forms

Source page 800

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

First line only; read the complete Indications and dose section above.

250 micrograms once daily, dose to be

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 800

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.